# ANHYDROUS TRISODIUM CITRATE

URL: https://app.greenveil.ai/ingredients/ingredient_dtxsid_dtxsid2026363
Categories: beauty, cleaning, food, industrial, pharma
Functions: Chelating agent, Deodorizer, Flavouring and nutrient, Fragrance, No specific technical function, Pharmaceutical, Preservative, Processing aids not otherwise specified, Stabilizing agent, Surfactant (surface active agent), Thickening agent, pH regulating agent
Identifier: DTXSID2026363

> ANHYDROUS TRISODIUM CITRATE is used as chelating agent / deodorizer. EPA CPDat observed this chemical in 3562 composition records across product categories including Construction and building materials, Specialty occupational products, Cleaning and safety. Assessed from 37 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: EPA CPDat observed this chemical in 3562 composition records across product categories including Construction and building materials, Specialty occupational products, Cleaning and safety.

## Regulatory status

- US: commercial use observed — EPA CPDat observed this chemical in 3562 composition records across product categories including Construction and building materials, Specialty occupational products, Cleaning and safety. EPA CPDat classifies this chemical for functional uses including Chelating agent, pH regulating agent, Deodorizer.
- US: inactive ingredient database — Route: INTRA-ARTICULAR; Dosage form: INJECTION; Maximum daily exposure: 22 mg
- US: inactive ingredient database — Route: INTRABURSAL; Dosage form: INJECTION; Potency: 1 %w/v
- US: inactive ingredient database — Route: INTRALESIONAL; Dosage form: INJECTION; Maximum daily exposure: 22 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION; Maximum daily exposure: 792 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, FOR SOLUTION; Maximum daily exposure: 240 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: CONCENTRATE; Maximum daily exposure: 24 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 792 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Maximum daily exposure: 240 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 24 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: SOLUTION, CONCENTRATE; Maximum daily exposure: 24 mg
- US: inactive ingredient database — Route: NASAL; Dosage form: SPRAY; Maximum daily exposure: 8 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE, EFFERVESCENT; Potency: 935 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Maximum daily exposure: 4000 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: POWDER, FOR SOLUTION; Potency: 48 mg/5ml
- US: inactive ingredient database — Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 320 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 240 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 21 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 47 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SYRUP; Maximum daily exposure: 156 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 720 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, CHEWABLE; Potency: 72.5 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Potency: 15 mg
- US: inactive ingredient database — Route: RESPIRATORY (INHALATION); Dosage form: SUSPENSION; Maximum daily exposure: 2 mg
- US: inactive ingredient database — Route: SOFT TISSUE; Dosage form: INJECTION; Maximum daily exposure: 22 mg
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION; Potency: 0.94 %w/v
- US: inactive ingredient database — Route: SUBLINGUAL; Dosage form: FILM; Maximum daily exposure: 4 mg
- US: inactive ingredient database — Route: SUBLINGUAL; Dosage form: TABLET; Maximum daily exposure: 36 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: CREAM; Maximum daily exposure: 4 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: LOTION; Potency: 0.08 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: SOLUTION; Potency: 0.1 %w/v
- US: marketed drug occurrence — FDA NDC lists this ingredient in 1 active drug products and 1 total products.
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as chemical.
- US: observed in branded food ingredient statements — Observed in 1 USDA branded foods including 1.75L Bloody Mary with Horseradish (MED).

_Assessed by Greenveil._